Alison B. Fleming

In Vitro Cytotoxicity and in Vivo Distribution after Direct Delivery of PEG−Camptothecin Conjugates to the Rat Brain

Alison B. Fleming, Kraig Haverstick, W. Mark Saltzman · Bioconjugate Chemistry · 2004 · 65 citations

Tissue Engineering, Ethylene Glycol, Engineering +18

Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties

Jeff Gudin, Naama Levy‐Cooperman, Ernest A. Kopecky et al. · Pain Medicine · 2015 · 44 citations · Full text

A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain

Nathaniel P. Katz, Ernest A. Kopecky, Melinda O’Connor et al. · Pain · 2015 · 35 citations

Pain Therapy, Pain Disorders, Pain Medicine +28

Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: An extended-release, abuse-deterrent formulation

Ernest A. Kopecky, Alison B. Fleming, Patrick K. Noonan et al. · Journal of Opioid Management · 2014 · 32 citations

Oral Human Abuse Potential of Oxycodone DETERx^®(Xtampza^®ER)

Ernest A. Kopecky, Alison B. Fleming, Naama Levy‐Cooperman et al. · The Journal of Clinical Pharmacology · 2016 · 30 citations · Full text